The Journal of Allergy and Clinical Immunology: In Practice
Clinical CommunicationsMeasuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumab
References (10)
- et al.
Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis
J Allergy Clin Immunol Pract
(2015) - et al.
Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis
J Allergy Clin Immunol
(1984) - et al.
Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab
J Allergy Clin Immunol Pract
(2014) - et al.
Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis
Ann Intern Med
(1977) Allergic bronchopulmonary aspergillosis
Chest
(2009)
Cited by (0)
The research activity of I.B. was partly supported by Instituto de Salud Carlos III – AES 2013, Programme Juan Rodés JR13/012.
Conflicts of interest: I. Bobolea has received payments from Novartis Farmaceutica for lectures, consultancy, and traveling to scientific meetings. C. F. Rodriguez has received travel support from National Congress, SEAIC (Allergy Society in Spain). C. M. Moreno has received payments from Novartis Farmaceutica for lectures, consultancy, and traveling to scientific meetings; consultancy fees from Boehringer Ingelheim and GlaxoSmithKline; has provided expert testimony for Chiesi; has received lecture fees from Novartis and Teva; has received payment for the development of educational presentations from GlaxoSmithKline; and has received travel support from Teva. The rest of the authors declare that they have no relevant conflicts of interest.